Microba Life Sciences Limited (ASX:MAP)
0.0360
+0.0010 (2.86%)
At close: Nov 13, 2026
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 25.21 million as of November 16, 2026. It is the 37,790th most valuable company in the world and the 979th biggest in Australia. Its market cap has decreased by 48.25% in one year.
Market Cap
25.21M
Enterprise Value
21.37M
Revenue
14.76M
Global Rank
Country Rank
#979 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 25.21M, a decrease of -73.75%. That is a compound annual growth rate of -25.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 25.21M | -45.53% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 621.12M |
| Healius | 432.06M |
| Monash IVF Group | 294.17M |
| Identifai Genetics | 80.63M |
| Cryosite | 59.55M |
| Rhythm Biosciences | 23.36M |
| BCAL Diagnostics | 22.12M |
| ImExHS | 17.95M |